---
figid: PMC7264916__aps-2020-00591f1
figtitle: Mutations and signaling pathways in vascular anomalies
organisms:
- NA
pmcid: PMC7264916
filename: aps-2020-00591f1.jpg
figlink: pmc/articles/PMC7264916/figure/f1-aps-2020-00591/
number: F1
caption: Mutations in vascular abnormalities affect genes involved in tyrosine kinase
  signaling via the RAS or PIK3CA pathways. This figure is a schematic diagram of
  key genetic mutations related to signal transduction and vascular malformations
  in endothelial cells. Proteins mutated in other vascular disorders are indicated.
  Mutations in GNAQ/GNA11/GNA14, RASA1, and KRIT lead to constitutive activation of
  RAS/RAF/MEK/ERK signaling. Mutations in TIE2/TEK lead to permanent activation of
  the PIK3CA/AKT/mTOR pathway. AVM, arteriovenous malformation; BAVM, brain arteriovenous
  malformation; BRBNS, blue rubber bleb nevus syndrome; BRRS, Bannayan-Riley-Ruvalcaba
  syndrome; CCM, cerebral cavernous malformation; CH, congenital hemangioma; CLAPOS,
  CLAPO syndrome; CLM, cystic lymphatic malformation; CLOVESS, CLOVES syndrome; CM,
  capillary malformation; CommonVM, common venous malformation; CMAVM, capillary malformation–arteriovenous
  malformation 1,2; CMOM, capillary malformation of macrocephaly; CVM, cutaneomucosal
  venous malformation; CH DCM, diffuse capillary malformation; EAVM, extracranial
  arteriovenous malformation; FIL, facial infiltrating lipomatosis; FAVA, fibroadipose
  vascular anomaly; VMCM, Familial venous malformation cutaneous and mucosal; HHT,
  hereditary hemorrhagic telangiectasia; IM, infantile myofibroma; JPHT, juvenile
  polyposis hemorrhagic telangiectasia; KHE, kaposiform hemangioendothelioma; KTS,
  Klippel-Trenaunay syndrome; LCMCNPLOG, limb capillary malformation with congenital
  nonprogressive limb overgrowth; MD, Milroy’s disease; MCM, megalencephaly capillary
  malformation; NSCM, non-syndromic capillary malformation; PL, primary lymphedema;
  PS, Proteus syndrome; PTHS, PTEN hamartoma syndrome; PG, pyogenic granuloma; PWS,
  Parkes Weber syndrome; PWSWM, port wine stain with macrocheilia; SVAM, spinal arteriovenous
  malformation; SWS, Surge-Weber syndrome; TA, tufted angioma; VM, venous malformation;
  VVM, verrucous venous malformation.
papertitle: 'The molecular pathophysiology of vascular anomalies: Genomic research.'
reftext: Jong Seong Kim, et al. Arch Plast Surg. 2020 May;47(3):203-208.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9078352
figid_alias: PMC7264916__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7264916__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7264916__aps-2020-00591f1.html
  '@type': Dataset
  description: Mutations in vascular abnormalities affect genes involved in tyrosine
    kinase signaling via the RAS or PIK3CA pathways. This figure is a schematic diagram
    of key genetic mutations related to signal transduction and vascular malformations
    in endothelial cells. Proteins mutated in other vascular disorders are indicated.
    Mutations in GNAQ/GNA11/GNA14, RASA1, and KRIT lead to constitutive activation
    of RAS/RAF/MEK/ERK signaling. Mutations in TIE2/TEK lead to permanent activation
    of the PIK3CA/AKT/mTOR pathway. AVM, arteriovenous malformation; BAVM, brain arteriovenous
    malformation; BRBNS, blue rubber bleb nevus syndrome; BRRS, Bannayan-Riley-Ruvalcaba
    syndrome; CCM, cerebral cavernous malformation; CH, congenital hemangioma; CLAPOS,
    CLAPO syndrome; CLM, cystic lymphatic malformation; CLOVESS, CLOVES syndrome;
    CM, capillary malformation; CommonVM, common venous malformation; CMAVM, capillary
    malformation–arteriovenous malformation 1,2; CMOM, capillary malformation of macrocephaly;
    CVM, cutaneomucosal venous malformation; CH DCM, diffuse capillary malformation;
    EAVM, extracranial arteriovenous malformation; FIL, facial infiltrating lipomatosis;
    FAVA, fibroadipose vascular anomaly; VMCM, Familial venous malformation cutaneous
    and mucosal; HHT, hereditary hemorrhagic telangiectasia; IM, infantile myofibroma;
    JPHT, juvenile polyposis hemorrhagic telangiectasia; KHE, kaposiform hemangioendothelioma;
    KTS, Klippel-Trenaunay syndrome; LCMCNPLOG, limb capillary malformation with congenital
    nonprogressive limb overgrowth; MD, Milroy’s disease; MCM, megalencephaly capillary
    malformation; NSCM, non-syndromic capillary malformation; PL, primary lymphedema;
    PS, Proteus syndrome; PTHS, PTEN hamartoma syndrome; PG, pyogenic granuloma; PWS,
    Parkes Weber syndrome; PWSWM, port wine stain with macrocheilia; SVAM, spinal
    arteriovenous malformation; SWS, Surge-Weber syndrome; TA, tufted angioma; VM,
    venous malformation; VVM, verrucous venous malformation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - LETM1
  - EPHB4
  - PDCD10
  - RASA1
  - SYNGAP1
  - LIFR
  - PNPLA6
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TKTL1
  - TEK
  - ABL1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - EPHB2
  - MAPK1
  - MAPK3
  - PDGFRB
  - AKT1
  - AKT2
  - AKT3
  - FLT4
  - KDR
  - PIK3CA
  - KTWS
  - LAMB1
  - CST9
  - MMUT
  - MCM2
  - MCM3
  - MCM4
  - MCM5
  - MCM6
  - MCM7
  - MCM8
  - MCM9
  - MCMDC2
  - MTOR
  - ENG
  - SMAD1
  - GARS1
  - SMAD5
  - SMAD9
  - SMAD4
  - SMAD6
  - SMAD7
  - SMAD2
  - SMAD3
  - GDF2
  - BMP10
  - ACVRL1
  - PTEN
  - TCF4
  - CCM
  - CH
  - Vemurafenib
  - Trametinib
  - PG VVM SAVM
  - AVM EAVM
  - Rapamycin
  - CM CH DCM
  - NSCM CM CH
  - PWS
---
